A study identifies the endocannabinoid system as a potential therapeutic target in severe acute pancreatitis
A study led by researchers from the Respitatory and Immune Repair (REPAIR) group at IGTP has identified alterations in the endocannabinoid system associated with the most severe forms of acute pancreatitis. The findings, published in The Journal of Pathology, describe a disruption linked to the most severe forms of the disease and point to the potential of the endocannabinoid system as both a biomarker of severity and a future therapeutic target.